Know What's Happening in Healthcare

Today's Healthcare Pulse

Allogene Therapeutics CEO David Chang to step down

Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.

Everads Therapy Publishes First-in-Human Data on Suprachoroidal Injector
NewsMay 4, 2026

Everads Therapy Publishes First-in-Human Data on Suprachoroidal Injector

Everads Therapy announced the publication of first-in-human trial data for its suprachoroidal injector, demonstrating safety, tolerability and rapid posterior drug distribution in patients with diabetic macular edema. The results, appearing in Ophthalmology Science, were showcased at the ARVO 2026 meeting,...

By Pulse
CIS News
BlogMay 4, 2026

CIS News

The latest roundup of surgical‑robotics news shows a surge of regulatory wins, funding rounds, and first‑in‑human procedures. Medtronic’s Stealth AXiS platform earned a CE mark and was deployed by U.S. surgeons for the first time, while EndoQuest secured $30 million to...

By SurgRob
Module 4, Section 2: All About Assays
BlogMay 4, 2026

Module 4, Section 2: All About Assays

The Module 4, Section 2 briefing provides a concise overview of modern assay platforms used in early‑stage drug discovery. It references key literature on PRMT5 fragment‑based screening that produced the MRTX1719 candidate, as well as thermal‑shift, surface plasmon resonance (SPR), and polymerase...

By Drug Hunter
Tailoring AI Solutions for Health Care Needs
NewsMay 4, 2026

Tailoring AI Solutions for Health Care Needs

AI is rapidly reshaping health care, with the FDA approving more than 1,300 AI‑enabled medical devices—over half in the past three years—and a surge in non‑device AI for administrative tasks. Mayo Clinic Platform stresses that successful tools must blend deep...

By MIT Technology Review
Needle-Free Diabetes Care: 6 Devices that Painlessly Monitor Blood Sugar
NewsMay 4, 2026

Needle-Free Diabetes Care: 6 Devices that Painlessly Monitor Blood Sugar

Needle‑free glucose monitors are moving from research labs to commercial shelves, with six innovative devices highlighted for their non‑invasive approaches. Abbott’s FreeStyle Libre remains the market leader for interstitial sensing, while newcomers such as Occuity Indigo, D‑Pocket, Light Touch Technology,...

By Labiotech.eu
The Court Physician of the Therapeutic State
BlogMay 4, 2026

The Court Physician of the Therapeutic State

The essay frames Anthony Fauci’s three‑decade tenure at NIAID through Murray Rothbard’s analysis of state‑driven scientism and regulatory capture. It argues that the NIH functions as a monopsony, steering biomedical research toward patented vaccine platforms and gain‑of‑function bio‑security projects while...

By Malone News
In India, Medical Titles Debate Raises Public Health Concerns
NewsMay 4, 2026

In India, Medical Titles Debate Raises Public Health Concerns

India’s Kerala High Court ruled that physiotherapists and occupational therapists may use the prefix “Dr.” provided they add the suffix “PT,” a decision formalized in the 2025 Competency‑Based Curriculum for Physiotherapy. The ruling sparked sharp opposition from the Indian Medical...

By The Diplomat – Asia-Pacific
BEAM Wins TIME 100, Delivers First Gene Base Editing Cure
SocialMay 4, 2026

BEAM Wins TIME 100, Delivers First Gene Base Editing Cure

Congrats to $BEAM on being named as one of @TIME’s 100 most influential & innovative companies that are shaping the world & our future. @beamtx’s leading Gene Editing platform - Base editing, has achieved a significant milestone when KJ Muldoon...

By Yair Einhorn
Drug Side Effects Are Often the Main Effects
BlogMay 4, 2026

Drug Side Effects Are Often the Main Effects

The article argues that drug side effects are not peripheral accidents but integral parts of a medication’s primary pharmacological action. It explains that the same biochemical pathways that deliver therapeutic benefits also generate adverse outcomes, using aspirin, blood‑pressure agents, and...

By Dr.Sircus
The Current State of the Physician Workforce: 9 Notes
NewsMay 4, 2026

The Current State of the Physician Workforce: 9 Notes

The Health Resources and Services Administration projects a shortfall of 141,160 full‑time‑equivalent physicians by 2038, underscoring a deepening workforce gap. Hospital systems are increasingly recruiting without higher salaries, emphasizing culture, autonomy and personalized outreach. Visa processing delays have sidelined over...

By Becker’s Hospital Review
BioCryst Partners with Irish Affiliate of Neopharmed Gentili in ~$345M EU Commercialization Deal for Navenibart
NewsMay 4, 2026

BioCryst Partners with Irish Affiliate of Neopharmed Gentili in ~$345M EU Commercialization Deal for Navenibart

BioCryst Pharmaceuticals has signed a licensing agreement with the Irish affiliate of Neopharmed Gentili, granting exclusive rights to commercialize its long‑acting plasma kallikrein inhibitor, Navenibart, across the European Union. The deal provides BioCryst with a $70 million upfront payment and potential...

By PharmaShots
Regulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned - 09/23/2025
NewsMay 4, 2026

Regulatory Submissions with Real-World Evidence: Successes, Challenges, and Lessons Learned - 09/23/2025

In a September 23, 2025 speech, FDA Principal Deputy Commissioner Sara Brenner outlined how real‑world evidence (RWE) has been used to support regulatory decisions and announced the agency‑wide FDA‑RWE‑ACCELERATE initiative. She highlighted recent examples from CDER, CBER and CDRH, and introduced Sentinel 3.0,...

By FDA
ML Model Shows CPAP Cuts Heart Risk in Sleep Apnea
SocialMay 4, 2026

ML Model Shows CPAP Cuts Heart Risk in Sleep Apnea

As a medical school professor, I've long argued sleep apnea is undertreated metabolic disease in disguise. A new Mount Sinai study in Nature Communications Medicine adds a wrinkle... https://www.youtube.com/@RobertLufkinMD https://www.mountsinai.org/about/newsroom/2026/mount-sinai-researchers-develop-machine-learning-model-to-predict-how-cpap-affects-cardiovascular-disease-risk-in-patients-with-obstructive-sleep-apnea SleepApnea #CPAP #MetabolicHealth #PrecisionMedicine #HealthLongevitySecrets

By Robert Lufkin, MD
Dana-Farber Mega-Deal Pays for Cancer Center and Refunding
NewsMay 4, 2026

Dana-Farber Mega-Deal Pays for Cancer Center and Refunding

Dana‑Farber Cancer Institute issued $1.4 billion of municipal revenue bonds (Series Q and R) to fund half of a new 300‑bed cancer‑hospital tower and to refinance nearly all existing debt. The first tranche of $1.304 billion carries yields from 3.57% to 4.84% and...

By The Bond Buyer (municipal finance)
Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
NewsMay 4, 2026

Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

Sonire Therapeutics announced the launch of SUNRISE‑II, its first U.S. clinical trial evaluating a proprietary high‑intensity focused ultrasound (HIFU) system for pancreatic cancer. The study will enroll roughly 10 patients to assess safety and feasibility. The inaugural patient was treated...

By MedTech Intelligence
Using AI to Anticipate Healthcare Air Quality Risks
NewsMay 4, 2026

Using AI to Anticipate Healthcare Air Quality Risks

Healthcare facilities are turning to AI‑driven air‑quality platforms to move from reactive monitoring to predictive protection. By fusing IoT sensor streams with machine‑learning models, systems like SensusAir can forecast spikes in pathogens, humidity or chemical pollutants hours before they endanger...

By IT News Africa
Center for Drug Evaluation and Research Organization Chart
NewsMay 4, 2026

Center for Drug Evaluation and Research Organization Chart

The U.S. Food and Drug Administration has published an updated Center for Drug Evaluation and Research (CDER) organization chart effective May 1 2026. The visual diagram outlines the current leadership hierarchy, reporting lines, and functional units overseeing drug regulation. Accompanying the image...

By FDA
Novel In-Hospital Screening Method Detects Cognitive Issues
NewsMay 4, 2026

Novel In-Hospital Screening Method Detects Cognitive Issues

Cedars‑Sinai investigators introduced a multicomponent in‑hospital screening that combines brief nursing assessments with an electronic health‑record algorithm to identify cognitive impairment and dementia in patients over 65. In a rollout covering more than 11,000 admissions, the program screened over 80%...

By Medical Xpress
Here's How Medication Abortion Works with Just One Drug That's Still Fully Available
NewsMay 4, 2026

Here's How Medication Abortion Works with Just One Drug That's Still Fully Available

A federal appeals court ordered the FDA to revert to in‑person prescribing rules for mifepristone, overturning the Biden administration’s telehealth flexibility. The decision takes effect nationwide, while the makers of mifepristone have appealed to the Supreme Court for a rapid...

By NPR (Health)
The CDC Keeps Stats on Everything, but Here’s One Thing They Have No Number For
BlogMay 4, 2026

The CDC Keeps Stats on Everything, but Here’s One Thing They Have No Number For

The CDC tracks individual childhood vaccines but does not publish a single figure for how many U.S. children have received the full complement of 72 recommended doses by age 18. The 72‑dose ceiling includes recent schedule changes, such as six...

By Jon Rappoport
OpenAI Made a Special ChatGPT for Your Doctor
NewsMay 4, 2026

OpenAI Made a Special ChatGPT for Your Doctor

OpenAI unveiled ChatGPT for Clinicians, a free, HIPAA‑compliant AI assistant built on its GPT‑5.4 model and tailored with health‑specific tools. The service targets doctors, nurses, physician assistants and pharmacists, pulling answers from peer‑reviewed studies, clinical guidelines and public‑health guidance. In...

By CNET (All)
Celcuity Reports the P-III (VIKTORIA-1) Trial Data on Gedatolisib Combination for HR+/HER2- PIK3CA Mutant Advanced Breast Cancer
NewsMay 4, 2026

Celcuity Reports the P-III (VIKTORIA-1) Trial Data on Gedatolisib Combination for HR+/HER2- PIK3CA Mutant Advanced Breast Cancer

Celcuity announced phase‑III VIKTORIA‑1 data showing that gedatolisib combined with fulvestrant, with or without palbociclib, achieved a statistically significant improvement in progression‑free survival (PFS) versus the alpelisib‑fulvestrant standard of care in HR+/HER2‑ advanced breast cancer patients harboring PIK3CA mutations. The...

By PharmaShots
The Power of Real World Data to Study Women’s Health at Scale
NewsMay 4, 2026

The Power of Real World Data to Study Women’s Health at Scale

Veradigm released its 2026 Women’s Health Report, leveraging real‑world evidence from its network of electronic health records linked to claims data. The report maps health trends across adolescence, reproductive years, and peri/post‑menopause, highlighting disease risk, comorbidities, and treatment patterns unique...

By MedCity News
Beyond Concierge Medicine: The Rise of Retained Health Management for Founders
NewsMay 4, 2026

Beyond Concierge Medicine: The Rise of Retained Health Management for Founders

Brad Pierce, co‑founder of Human Sync, argues that founders treat their bodies like an unmanaged asset, relying on annual physicals or concierge medicine that only speed access. He proposes a retained health‑management model that continuously monitors biomarkers, genetics and performance,...

By HIT Consultant
New Senate Report Warns Medicare Premiums Could Double by 2035, Squeezing Social Security Checks
BlogMay 4, 2026

New Senate Report Warns Medicare Premiums Could Double by 2035, Squeezing Social Security Checks

A Senate Joint Economic Committee report warns that Medicare Part B premiums could climb from about $2,200 today to $4,500‑$5,000 per year by 2035, effectively doubling costs for seniors. The surge reflects projected Medicare spending growth, with premiums automatically adjusted to...

By Financial Freedom Countdown
Drugmaker AbbVie Chooses North Carolina for $1.4B Manufacturing Campus
NewsMay 4, 2026

Drugmaker AbbVie Chooses North Carolina for $1.4B Manufacturing Campus

AbbVie announced a $1.4 billion investment to build a 185‑acre manufacturing campus in Durham, North Carolina, targeting its immunology, neuroscience and oncology portfolios. The site will create 734 jobs over four years, incorporate AI‑driven production tools, and be operational by the...

By Supply Chain Dive
Use of Hepatitis C-Positive Donors Reduces Pancreas Transplant Wait Times
NewsMay 4, 2026

Use of Hepatitis C-Positive Donors Reduces Pancreas Transplant Wait Times

Researchers at Cedars‑Sinai Health Sciences found that using hepatitis C‑positive pancreas donors slashes wait times by an average of 117 days. The study, published in the American Journal of Transplantation, shows that recipients of HCV‑positive organs enjoy comparable graft function and...

By Medical Xpress
Murata Ramps up Ultra-Low Power AMR Sensor Output for Wearable and IoT Use
NewsMay 4, 2026

Murata Ramps up Ultra-Low Power AMR Sensor Output for Wearable and IoT Use

Murata Manufacturing has started mass production of two ultra‑low power anisotropic magnetoresistance (AMR) sensors, the MRMS166R and MRMS168R, aimed at wearables, healthcare devices, and IoT applications. The MRMS166R draws only about 20 nA at 1.2 V, enabling standby periods of over two...

By SemiMedia Global
Michigan Mother Says She Believes COVID Vaccine Played Role in 17-Year-Old Daughter’s Death, Reacts to Findings From U.S. Sen. Ron...
BlogMay 4, 2026

Michigan Mother Says She Believes COVID Vaccine Played Role in 17-Year-Old Daughter’s Death, Reacts to Findings From U.S. Sen. Ron...

A Michigan mother, Shanna Carroll, alleges that the COVID‑19 vaccine contributed to her 17‑year‑old daughter Aubrynn Grundy's death in August 2022. The claim resurfaces after U.S. Sen. Ron Johnson released findings questioning whether federal officials adequately warned the public about...

By Dave Bondy's Keeping it Real Newsletter
How Minor Injuries Lead to Flesh-Eating Bacteria in Rural Nigeria
BlogMay 4, 2026

How Minor Injuries Lead to Flesh-Eating Bacteria in Rural Nigeria

In rural Nigeria, minor injuries such as thorns or needle pricks frequently progress to necrotizing fasciitis, a flesh‑eating bacterial infection. Delayed presentation, limited clinic access, poverty, and low wound‑care awareness turn treatable cuts into life‑threatening conditions, often requiring urgent debridement...

By KevinMD
Seeing Keratoconus Earlier with Light Polarization and AI
NewsMay 4, 2026

Seeing Keratoconus Earlier with Light Polarization and AI

Researchers combined polarization‑sensitive optical coherence tomography (PS‑OCT) with artificial‑intelligence algorithms to improve detection of subclinical keratoconus. In a study of 359 eyes from Narayana Nethralaya, the PS‑OCT‑based model outperformed conventional shape‑based devices such as Pentacam and MS‑39 in identifying early...

By Medical Xpress
Solving the $150B No-Show Problem: The Rise of Healthcare Conversation Intelligence
NewsMay 4, 2026

Solving the $150B No-Show Problem: The Rise of Healthcare Conversation Intelligence

Healthcare providers lose up to $150 billion a year to missed appointments, a problem that persists despite the phone’s central role in patient access. Conversation intelligence—AI‑driven analysis of call content, sentiment, and outcomes—turns unstructured voice data into scalable insights. By flagging...

By HIT Consultant
How a Vision-Restoring Gene Therapy Proved that We Can Treat Inherited Diseases
NewsMay 4, 2026

How a Vision-Restoring Gene Therapy Proved that We Can Treat Inherited Diseases

Luxturna, the first FDA‑approved gene‑augmenting therapy for inherited retinal disease, received the 2026 Breakthrough Prize after restoring sight to patients with Leber’s congenital amaurosis type 2. Developed by Spark Therapeutics founders Katherine High, Jean Bennett and surgeon Albert Maguire, the treatment...

By Scientific American – Mind
Obesity Ends Oncology’s Long Reign as Top Contributor to Biopharma Pipeline Value
NewsMay 4, 2026

Obesity Ends Oncology’s Long Reign as Top Contributor to Biopharma Pipeline Value

Deloitte’s 2025 pipeline analysis shows obesity overtaking oncology as the top value‑generating therapeutic area, accounting for 25% of total pipeline worth. Eli Lilly and Novo Nordisk dominate the obesity segment, together holding roughly 96% of its assigned value. GLP‑1/GIP agonists are driving...

By BioSpace
New U.S. Dietary Guidelines Flip Food Pyramid Upside Down, Sparking Confusion
NewsMay 4, 2026

New U.S. Dietary Guidelines Flip Food Pyramid Upside Down, Sparking Confusion

The 2025‑2030 Dietary Guidelines for Americans were released at the start of 2026 featuring an inverted food pyramid. Nutrition experts say the visual and its emphasis on grains, red meat and saturated fats could mislead consumers and affect school‑meal programs....

By Pulse
A $20B Aesthetics Boom Hides Dangerous Unlicensed Injectors
SocialMay 4, 2026

A $20B Aesthetics Boom Hides Dangerous Unlicensed Injectors

The aesthetics industry is now a 20 billion dollar business. Roughly the size of the NFL. Almost no one is checking who is holding the needle. Last year, people in 11 states ended up in the hospital from fake Botox...

By Kevin Pho, MD
Health Tech Adoption Ignores Clinical Evidence, Despite Building It
SocialMay 4, 2026

Health Tech Adoption Ignores Clinical Evidence, Despite Building It

The uncomfortable truth is that when it comes to Health Tech, clinical evidence is neither sufficient nor perhaps even necessary to drive adoption of change in healthcare This is not a new phenomenon - been living this the last 13+ years...

By Joshua Liu, MD
ICE Has Not Paid for Detainee Medical Care for 7 Months
BlogMay 4, 2026

ICE Has Not Paid for Detainee Medical Care for 7 Months

On October 3 2025 the Trump administration halted reimbursements to third‑party providers for ICE detainee medical care, creating a seven‑month payment gap. The pause coincided with a sharp rise in detainee deaths, jumping from an average of 9 per year to 33...

By Popular Information
Telepresence Robots Let Doctors Conduct Remote Hospital Rounds
SocialMay 4, 2026

Telepresence Robots Let Doctors Conduct Remote Hospital Rounds

Telepresence #Robots Transform #Healthcare: Remote Doctors Now Make Hospital Rounds by @sutoroveli_news #MedTech #HealthTech #TechForGood #Tech https://t.co/fS31GfoXwT

By Ron van Loon
Nonprofit Hospitals Receive $37 Billion in Tax Subsidies
SocialMay 4, 2026

Nonprofit Hospitals Receive $37 Billion in Tax Subsidies

My latest op-ed. "The hospital sector is unlike any other. More than half of all U.S. hospitals operate as nonprofits, which sounds like a public good. No profit motive, more resources for patients, right? Wrong." The $37 billion tax subsidy propping...

By Scott Hodge
The Federal Government Didn’t Legalize Marijuana. Here’s What Actually Changed.
NewsMay 4, 2026

The Federal Government Didn’t Legalize Marijuana. Here’s What Actually Changed.

On April 23 the Justice Department reclassified state‑licensed and FDA‑approved medical marijuana products from Schedule I to Schedule III. The move does not legalize cannabis federally but opens the door for tax deductions, retroactive refunds, and fewer research barriers. It signals a...

By Poynter
Rome Surgeon Conducts 8,000‑km Remote Robotic Surgery
SocialMay 4, 2026

Rome Surgeon Conducts 8,000‑km Remote Robotic Surgery

Surgeon in Rome performs remote #Robotic surgery on patient 8,000 km away in Beijing by @InterestingSTEM #Healthcare #Healthech #Tech #Technology #EmergingTech #TechForGood https://t.co/d2OJ7mZgD8

By Ron van Loon
Top AI Researcher Departs Genentech, Rethinks Pharma Future
SocialMay 4, 2026

Top AI Researcher Departs Genentech, Rethinks Pharma Future

“It got a bit too distant for me." Some insights into big pharma & AI from @kchonyc, a top AI researcher who talked with me about leaving Roche's Genentech and what he's thinking about next: https://t.co/IvzWUjc9Qd

By Andrew Dunn
FDA Greenlights First Ibogaine Trial as Hype Eclipses Limited Data
NewsMay 4, 2026

FDA Greenlights First Ibogaine Trial as Hype Eclipses Limited Data

The U.S. Food and Drug Administration announced it will permit the first clinical trial of ibogaine, a psychedelic derived from a West African shrub, after President Donald Trump highlighted the drug at a White House event. Researchers caution that the...

By Pulse
Aluminum Remains in Vaccines and Human Brains
SocialMay 4, 2026

Aluminum Remains in Vaccines and Human Brains

To the medical doctor with a PhD. No, aluminum has not been removed from vaccines. It also hasn’t been removed from people’s brains. 🧠🧠🧠 https://t.co/MLcgLr2ro0

By Robyn O’Brien
Heidi AI Expands to South Africa, Spurring Clinician‑led AI Adoption
NewsMay 4, 2026

Heidi AI Expands to South Africa, Spurring Clinician‑led AI Adoption

Heidi AI has launched its clinician‑led AI platform across South Africa, reaching more than 1.5 million consultations each month and posting a 500% year‑on‑year rise in weekly active use. The expansion leverages seamless integration with local practice‑management systems and targets a...

By Pulse
Express Delegation Still Means What It Says: Sixth Circuit Upholds DOL Home Care Rule After Loper Bright
NewsMay 4, 2026

Express Delegation Still Means What It Says: Sixth Circuit Upholds DOL Home Care Rule After Loper Bright

On April 1 2026 the Sixth Circuit upheld the Department of Labor’s 2013 rule that requires third‑party home‑care agencies to pay overtime, even for live‑in caregivers caring for family members. The court ruled that Congress’s express delegation of authority to the DOL...

By HR Daily Advisor
The Reality of Social Security and Medicare- My Real Life Experience.
BlogMay 4, 2026

The Reality of Social Security and Medicare- My Real Life Experience.

A retiree who paid $132,817 in Social Security taxes (1959‑2010) and an equal amount from his employer now reports receiving roughly $798,750 in combined benefits since 2008, surpassing his contributions after six years. He also paid $98,080 in Medicare taxes,...

By Humbledollar
Three Dead as Hantavirus Strikes Atlantic Cruise Ship, WHO Confirms
NewsMay 4, 2026

Three Dead as Hantavirus Strikes Atlantic Cruise Ship, WHO Confirms

The World Health Organization confirmed that three passengers died and one case of hantavirus was laboratory‑verified on the MV Hondius, a Netherlands‑operated expedition cruise in the Atlantic. Six people fell ill, with two more evacuated for intensive care, sparking an...

By Pulse